Aziyo Biologics, Inc. (AZYO)

7.00 +0.66 (+10.41%) At close: 04:00PM EST

Aziyo Biologics, Inc.

12510 Prosperity Drive
Suite 370
Silver Spring, MD 20904
United States
240 247 1147
https://www.aziyo.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 176

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ronald K. Lloyd	CEO, Pres & Director	890.57k	N/A	1961
Dr. Darryl Roberts Ph.D.	Exec. VP of Operations & Product Devel.	468.24k	N/A	1961
Dr. Jerome Riebman FACC, M.A., M.D.	Chief Medical Officer	552.69k	N/A	1954
Mr. Matthew B. Ferguson	Chief Financial Officer	N/A	N/A	1968
Mr. Peter G. Edwards Esq.	Gen. Counsel	N/A	N/A	1961
Ms. Courtney Guyer	VP of Marketing	N/A	N/A	N/A
Mr. Thomas Englese	Chief Commercial Officer	N/A	N/A	1974
Mr. Jeffry D. Hamet	VP of Fin., Treasurer & Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Corporate Governance

Aziyo Biologics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.